CA2676061A1 — Macrocyclic polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereof
Assigned to Merck Sharp and Dohme LLC · Expires 2008-07-31 · 18y expired
What this patent protects
The invention relates to novel forms of compounds displaying broad spectr um antibiotic activity, especially crystalline polymorphic forms and amorpho us forms of such compounds, compositions comprising such crystalline polymor phic forms and amorphous forms of such compounds, pr…
USPTO Abstract
The invention relates to novel forms of compounds displaying broad spectr um antibiotic activity, especially crystalline polymorphic forms and amorpho us forms of such compounds, compositions comprising such crystalline polymor phic forms and amorphous forms of such compounds, processes for manufacture and use thereof. The compounds and compositions of the invention are useful in the pharmaceutical industry, for example, in the treatment or prevention of diseases or disorders associated with the use of antibiotics, chemotherap ies, or antiviral therapies, including, but not limited to, colitis, for exa mple, pseudo-membranous colitis; antibiotic associated diarrhea; and infecti ons due to Clostridium difficile ("C. difficile"), Clostridium perfringens ( "C. perfringens"), Staphylococcus species, for example, methicillin-resistan t Staphylococcus, or Enterococcus including Vancomycin-resistant enterococci .
Drugs covered by this patent
- Dificid (FIDAXOMICIN) · Cubist Pharms Llc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.